Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?-Reference-Cited by-同舟云学术

Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?

Published:2021-12-03 Issue: Volume: Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

Focosi Daniele¹^ORCID,Franchini Massimo²,Pirofski Liise‐anne³,Maggi Fabrizio⁴⁵,Casadevall Arturo⁶

Affiliation:

1. North‐Western Tuscany Blood Bank Pisa University Hospital Pisa Italy

2. Division of Transfusion Medicine Carlo Poma Hospital Mantua Italy

3. Division of Infectious Diseases Departments of Medicine, Microbiology and Immunology Albert Einstein College of Medicine and Montefiore Medical Center New York City New York USA

4. Department of Medicine and Surgery University of Insubria Varese Italy

5. Laboratory of Microbiology ASST Sette Laghi Varese Italy

6. Department of Medicine Johns Hopkins School of Public Health and School of Medicine Baltimore Maryland USA

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2314

Reference104 articles.

1. Casirivimab and imdevimab in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label;Recovery Collaborative Group;medRxiv,2021

2. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

3. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

4. Subcutaneous REGEN‐COV antibody combination to prevent Covid‐19;O’Brien MP;N Engl J Med,2021

5. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis;The Lancet Microbe;2024-05

2. A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment;Viruses;2022-09-09

3. Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review;International Journal of Molecular Sciences;2021-12-21